Semaglutide has shifted the conversation around weight loss medication in a meaningful way. It is not a stimulant or a crash diet in a pill. It is a hormone-based therapy that targets the biological signals driving hunger, and the clinical evidence behind it is substantial. For men dealing with excess weight that has not responded to diet and exercise alone, understanding how semaglutide works is the first step toward making an informed decision.
What Is Semaglutide?
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. It is a synthetic analog of GLP-1, a hormone your gut naturally produces after eating. GLP-1 signals to the brain that you are full, slows gastric emptying, and helps regulate blood sugar. Semaglutide mimics this signal at a much higher potency and for a longer duration than your body produces naturally. ( 1 )
Originally developed to treat type 2 diabetes, semaglutide was later studied specifically for weight management. Clinical results from those trials prompted regulatory approval for chronic weight management in adults with obesity or overweight with at least one weight-related condition. ( 2 )
How Semaglutide Works for Weight Loss
The mechanism behind semaglutide is multifaceted. When it binds to GLP-1 receptors in the brain, particularly in the hypothalamus, it reduces appetite and food cravings. It also acts on the gut to delay how quickly food leaves the stomach, which extends the feeling of fullness after meals. ( 3 )
Beyond appetite suppression, research suggests semaglutide may influence reward-related eating behavior. A study published in Diabetes, Obesity and Metabolism found that participants on semaglutide reported reduced cravings for high-fat foods and a lower drive to eat overall, independent of caloric restriction. ( 4 )
The result is a significant reduction in total caloric intake without the psychological strain of white-knuckling hunger. This distinguishes it from traditional calorie-cutting approaches that often fail because they fight biology rather than work with it.
Who Is a Candidate for Semaglutide?
Semaglutide is not a shortcut for people looking to lose a few vanity pounds. Clinically, it is indicated for adults with a body mass index above a threshold level, or for those with a lower BMI who carry a weight-related comorbidity such as hypertension, type 2 diabetes, or sleep apnea. ( 5 )
For men specifically, excess weight often comes with hormonal consequences. Low testosterone is strongly associated with obesity, and the relationship is bidirectional: excess fat tissue increases the conversion of testosterone to estrogen, further disrupting hormonal balance. If you have noticed symptoms like fatigue, low libido, or mood changes alongside weight gain, a hormone panel is worth considering. You can learn more about how low testosterone affects men and how it overlaps with body composition issues.
Men with a personal or family history of certain thyroid cancers, pancreatitis, or those currently pregnant are typically not candidates for semaglutide. A thorough medical evaluation is essential before starting. ( 6 )
Common Myths About Semaglutide
Myth: Semaglutide Does the Work for You
Semaglutide is most effective when paired with dietary changes and increased physical activity. According to the STEP 1 trial published in the New England Journal of Medicine, participants who combined semaglutide with lifestyle intervention achieved significantly greater weight loss than those on placebo with the same lifestyle program. ( 7 ) The medication reduces the biological noise of hunger, but behavioral choices still matter.
Myth: The Weight Stays Off After You Stop
A follow-up study published in Diabetes, Obesity and Metabolism found that participants who discontinued semaglutide regained a substantial portion of their lost weight within a year. ( 8 ) Weight management is an ongoing process, and semaglutide is a tool, not a cure.
Myth: It Is Only for Diabetics
While semaglutide was first approved for type 2 diabetes management, a separate formulation has received approval specifically for chronic weight management in non-diabetic adults with obesity. The underlying biology applies regardless of diabetes status. ( 9 )
When to See a Doctor
If your weight is affecting your cardiovascular health, joint function, sleep quality, or hormonal profile, that is a medical problem that deserves a medical evaluation. A physician can assess whether semaglutide is appropriate, identify any contraindications, and monitor your progress safely.
It is also worth evaluating your hormonal health as part of this conversation. Research has shown that poor sleep impairs testosterone production and worsens metabolic function, both of which compound weight gain in men. Addressing these overlapping factors together produces better outcomes than treating weight in isolation.
Take the Next Step
Semaglutide represents a meaningful advancement in the medical approach to weight loss. If you have been struggling despite doing the right things with diet and exercise, the problem may be biological, not behavioral. Consult with a qualified healthcare provider to determine whether semaglutide is an appropriate part of your weight management strategy. We recommend working with a provider who understands the full hormonal picture, including how weight loss intersects with testosterone health and metabolic function.
Emergency Notice: If you or someone else is experiencing a medical emergency, call 911 immediately. The information on this site is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
References
- Drucker DJ. Mechanisms of action and therapeutic application of glucagon-like peptide-1. Cell Metabolism. 2018;27(4):740-756. https://doi.org/10.1016/j.cmet.2018.03.001
- Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). New England Journal of Medicine. 2021;384(11):989-1002. https://doi.org/10.1056/NEJMoa2032183
- Blundell J, Finlayson G, Axelsen M, et al. Effects of once-weekly semaglutide on appetite, energy intake, energy expenditure, and gastric emptying in adults with obesity. Diabetes, Obesity and Metabolism. 2017;19(9):1242-1251. https://doi.org/10.1111/dom.12932
- Wadden TA, Bailey TS, Billings LK, et al. Effect of subcutaneous semaglutide vs placebo as an adjunct to intensive behavioral therapy on body weight in adults with overweight or obesity. JAMA. 2021;325(14):1403-1413. https://doi.org/10.1001/jama.2021.1831
- Davies M, Faerch L, Jeppesen OK, et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2). Lancet. 2021;397(10278):971-984. https://doi.org/10.1016/S0140-6736(21)00213-0
- Marso SP, Daniels GH, Brown-Frandsen K, et al. Liraglutide and cardiovascular outcomes in type 2 diabetes (LEADER trial). New England Journal of Medicine. 2016;375(4):311-322. https://doi.org/10.1056/NEJMoa1603827
- Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). New England Journal of Medicine. 2021;384(11):989-1002. https://doi.org/10.1056/NEJMoa2032183
- Wilding JPH, Batterham RL, Davies M, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. Diabetes, Obesity and Metabolism. 2022;24(8):1553-1564. https://doi.org/10.1111/dom.14725
- Kushner RF, Calanna S, Davies M, et al. Semaglutide 2.4 mg for the treatment of obesity: key elements of the STEP trials 1 to 5. Obesity. 2020;28(6):1050-1061. https://doi.org/10.1002/oby.22794